JP2001038154A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001038154A5 JP2001038154A5 JP1999219788A JP21978899A JP2001038154A5 JP 2001038154 A5 JP2001038154 A5 JP 2001038154A5 JP 1999219788 A JP1999219788 A JP 1999219788A JP 21978899 A JP21978899 A JP 21978899A JP 2001038154 A5 JP2001038154 A5 JP 2001038154A5
- Authority
- JP
- Japan
- Prior art keywords
- plasma
- membrane
- minutes
- inner diameter
- separation membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 description 24
- 238000000926 separation method Methods 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 230000014759 maintenance of location Effects 0.000 description 8
- 102100027211 Albumin Human genes 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000012510 hollow fiber Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 102000006395 Globulins Human genes 0.000 description 4
- 108010044091 Globulins Proteins 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- -1 wet heat treatment Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 101710095674 Protein 6.5 Proteins 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11219788A JP2001038154A (ja) | 1999-08-03 | 1999-08-03 | 血漿成分の分離膜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11219788A JP2001038154A (ja) | 1999-08-03 | 1999-08-03 | 血漿成分の分離膜 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001038154A JP2001038154A (ja) | 2001-02-13 |
| JP2001038154A5 true JP2001038154A5 (enrdf_load_stackoverflow) | 2006-05-11 |
Family
ID=16741037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11219788A Pending JP2001038154A (ja) | 1999-08-03 | 1999-08-03 | 血漿成分の分離膜 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001038154A (enrdf_load_stackoverflow) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS596062A (ja) * | 1982-07-01 | 1984-01-13 | 株式会社クラレ | ポリペプタイド透過性に優れた人工腎臓用膜の製造方法 |
| JPH03196819A (ja) * | 1989-12-26 | 1991-08-28 | Asahi Chem Ind Co Ltd | マイコプラズマ除去方法 |
| JP3130331B2 (ja) * | 1991-05-20 | 2001-01-31 | テルモ株式会社 | 再生セルロース製中空糸膜および人工透析器 |
| JP3020016B2 (ja) * | 1994-06-24 | 2000-03-15 | 東洋紡績株式会社 | 中空糸膜 |
| JP2792556B2 (ja) * | 1994-12-16 | 1998-09-03 | 東洋紡績株式会社 | 血液浄化用モジュール、血液浄化膜及びその製造方法 |
| JP3253861B2 (ja) * | 1996-08-28 | 2002-02-04 | 帝人株式会社 | 選択透過性中空糸膜 |
| JPH10108907A (ja) * | 1996-10-08 | 1998-04-28 | Toyobo Co Ltd | 血液浄化膜、その製造方法及び血液浄化用モジュール |
| JP3295321B2 (ja) * | 1996-12-05 | 2002-06-24 | 帝人株式会社 | 選択透過性中空糸膜 |
-
1999
- 1999-08-03 JP JP11219788A patent/JP2001038154A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8197745B1 (en) | Perm selective asymmetric hollow fibre membrane for the separation of toxic mediators from blood | |
| JPH10108907A (ja) | 血液浄化膜、その製造方法及び血液浄化用モジュール | |
| JPH0642905B2 (ja) | 血液透析膜 | |
| KR100424995B1 (ko) | 선택투과성 막 및 그의 제조방법 | |
| JP3253861B2 (ja) | 選択透過性中空糸膜 | |
| JPH10263375A (ja) | 選択透過性中空糸膜 | |
| JP2001038154A5 (enrdf_load_stackoverflow) | ||
| JPH0548705B2 (enrdf_load_stackoverflow) | ||
| JP3020016B2 (ja) | 中空糸膜 | |
| JP3995228B2 (ja) | 血液浄化用中空糸膜 | |
| JP3651121B2 (ja) | 選択透過性分離膜 | |
| JPH0245062A (ja) | 血液濃縮器用中空糸膜 | |
| JP4055634B2 (ja) | 血液透析膜およびその製造方法 | |
| JP4003982B2 (ja) | ポリスルホン系選択透過性分離膜 | |
| JP2000325759A (ja) | 膜の製造方法 | |
| JP2003175321A (ja) | 中空糸状膜の製造方法 | |
| JP2001038169A5 (enrdf_load_stackoverflow) | ||
| JP2873967B2 (ja) | ポリアクリロニトリル系中空糸膜およびその製造法 | |
| JP4381058B2 (ja) | 血液適合性に優れた中空糸型血液浄化器 | |
| JP4381022B2 (ja) | 中空糸型血液浄化膜 | |
| JPH09308684A (ja) | 選択分離膜 | |
| JP4386607B2 (ja) | ポリスルホン系血液浄化膜の製造方法およびポリスルホン系血液浄化膜 | |
| JP2000210544A (ja) | 半透膜の製造方法 | |
| Perepechkin et al. | Hollow fibres for medical applications. A review | |
| JP2855725B2 (ja) | 血漿分離用多孔質中空糸膜 |